LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Company News/Spine Surgery Vending Machine Company Wins Economic Award
Company News

Spine Surgery Vending Machine Company Wins Economic Award

January 4, 2023 3 min read Premium comments

Advertisement

Spine Surgery Vending Machine Company Wins Economic Award
Xenco Medical’s Spinal Implant Vending Machine / Courtesy of Xenco Medical
Secondary#xencomedical#interfacialbonding#spinalimplants#sterilepackaging

San Diego, California-based Xenco Medical has received the 2022 New Champions Award for Excellence in Sustainable Growth by the prestigious World Economic Forum. This award recognizes exceptional efforts “in sending market signals and scaling innovative solutions for revitalizing societies” and “accelerating technology and innovation.”

“As an outcomes-oriented spinal technology company with an ongoing commitment to impact the entire continuum of a surgical patient’s journey, we are immensely honored by the World Economic Forum’s recognition of both the technical breakthroughs encapsulated in each of our surgical devices and the scale of distribution we have achieved,” Xenco Medical Founder and CEO Jason Haider told OTW.

Xenco has pioneered a new category of surgical implant systems with its sterile-packaged spinal implants pre-attached to disposable, composite polymer delivery instruments. According to the company, the highly reinforced, composite polymer instruments included with each of Xenco Medical’s implants allow for both consistent mechanical performance and the elimination of the costly logistics associated with the autoclave process.

On a pioneering roll, Xenco Medical has also introduced digitally driven technologies such as WiFi-enabled surgical vending machines for real-time inventory monitoring of Xenco Medical’s implant systems and the world’s first glasses-free holographic surgical simulation platform, enabling surgeons to translate 2-dimensional datasets such as CT and MRI scans into interactive, holographic reconstructions on a light field display.

When OTW asked what type of “market signals” the company is being recognized for, Haider noted, “The market signals Xenco Medical is being recognized for include nationwide adoption of our sterile-packaged spinal systems across both major health systems and outpatient surgery centers as well as accelerating growth in the number of healthcare facilities spearheading sterile-packaged spinal system initiatives to mitigate infection risks and boost surgical turnover times.”

Xenco’s sterile-packaged spinal implants, Haider said, “Are engineered to streamline intraoperative workflow, reduce healthcare facility costs, and eliminate the risk of surgical site infections due to improperly sterilized surgical instruments, each of our disposable, sterile-packaged spinal platforms has been designed through an interdisciplinary process for the value-based era of healthcare.”

“By leveraging materials science and gamma sterilization, we’ve been able to build a single-use model that eliminates the high overhead costs associated with the maintenance, reprocessing, and tracking of aging metal instruments. Fiber orientation, fiber length, and interfacial bond strength work in concert to create the durability of every Xenco Medical instrument. Using a combination of aligned and randomly oriented fibers, the material components complement each other to form a cohesive structure.”

“Attached to each of our lumbar and cervical spinal implants, the simultaneous durability and disposability of our lightweight yet remarkably strong delivery instruments can be attributed to their unique interfacial bond strength, allowing for a robust interaction between a matrix phase of semi-crystalline nylon, with its high impact strength and low internal tension, and a dispersed phase of uniquely oriented fibers. As the surgeon exerts force on the instrument during surgery, the high interfacial bonding is important in transmitting the stress from the matrix phase to the dispersed phase, which maximizes the instrument’s overall strength.”

Advertisement

“Our sterile-packaged cervical spine platform includes interbodies and plates pre-attached to our disposable delivery instruments for one, two, three, and four-level anterior cervical discectomy and fusion procedures.”

“Leveraging the same Xenco Medical composite-polymer platform, our single-use lumbar systems feature pre-attached ALIF [anterior lumbar interbody fusion], PLIF [posterior lumbar interbody fusion], TLIF [transforaminal lumbar interbody fusion], and oblique interbodies, including our biomimetic titanium foam CancelleX interbodies and our traditional PEEK interbodies.”

“Our single-use pedicle screw system features a comprehensive suite of essential instruments corresponding to our pedicle screws, including a composite-polymer torque-limiting driver. Every sterile-packaged Xenco Medical implant and instrument system is designed to be compatible with Xenco Medical’s surgical vending machines for real-time tracking and dispensing of our surgical inventory.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy